12:30 – 1:00 PM

Day One Welcome & Introductions

• Bo Gamble, Director of Quality & Value, Community Oncology Alliance
• Michael Diaz, MD, President & Managing Physician, Florida Cancer Specialists & Research Institute
• Lalan Wilfong, MD, Vice President, Payer Relations & Practice Transformation, The US Oncology Network, McKesson

1:00 – 1:55 PM

Practice Perspectives on the EOM: Why or Why Not Participate?
The Enhancing Oncology Model (EOM) is CMS’ latest effort to transform care for patients with cancer, reduce spending, and improve quality of care. A panel of different cancer care teams will discuss details of the model and why they are, or are not, participating in the EOM. 

• Sibel Blau, MD, President, Chief Executive Officer, Quality Cancer Care Alliance (QCCA), Medical Director, Oncology Division, Northwest Medical Specialties, PLLC
• Michael Diaz, MD, President & Managing Physician, Florida Cancer Specialists & Research Institute, Moderator
• Susan Escudier, MD, FACP, Vice President, Value-Based Care & Quality Programs, Texas Oncology
• Barbara McAneny, MD, FASCO, MACP, Chief Executive Officer, New Mexico Cancer Center, Ltd.

2:00 – 2:45 PM

Diverse Perspectives on What is High-Quality Cancer Care
High-quality cancer care is the goal of all stakeholders, but everyone from patients to payers to providers defines it differently. This panel discussion featuring a cancer survivor, employer, and oncologist will share the diverse perspectives on quality care and how we can collaborate to ensure all goals are met.

• Bo Gamble, Director of Quality & Value, Community Oncology Alliance, Moderator
• Park Ginder, PhD, Superintendent, Southwest Allen County Schools, Cancer Survivor
• Matthew Skelton, MD, Blue Ridge Cancer Care
• Chris Skisak, PhD, Executive Director, Houston Business Coalition on Health

2:50 – 3:45 PM

The Oncology Medical Home: A Comprehensive & Accountable Model for Quality Cancer Care
The Oncology Medical Home (OMH) is an all-encompassing model for identifying, standardizing, and validating high-quality cancer care. Join us for a comprehensive review of the OMH program, the care standards, and platform it offers for transforming cancer care payment and delivery.

• Chiara Battelli, MD, PhD, New England Cancer Specialists
• Bo Gamble, Director of Quality & Value, Community Oncology Alliance
• Steve Grubbs, MD, FASCO, Vice President Care Delivery, American Society of Clinical Oncology (ASCO)
• Kevin Svobada, CPA, CGMA, Chief Executive Officer, Central Georgia Cancer Care

3:50 – 4:45 PM

Demystifying Drug Prices: Better Understanding the Elephant in the Shadows
Whether you’re a patient, practice, or payer, drug prices are complicated. Hear from a national expert on demystifying the complicated world of drug prices and better understanding the elephant in the shadows of our cancer care system. 

• Brian Corvino, MBA, Managing Director, Life Sciences & Health Care Practice, Deloitte Consulting, LLP

4:50 – 5:45 PM

Can We Have a World Without PBMs? Alternative Solutions & Opportunities
Pharmacy benefit managers (PBMs) are a constant source of frustration for all. What if there were solutions to the PBM problem? In this session, we explore alternatives to the PBM model and opportunities to go beyond traditional PBM models.

• Greg Baker, RPh, Founder, Chief Executive Officer, EmsanaRx
• Michael Diaz, MD, President & Managing Physician, Florida Cancer Specialists & Research Institute, Moderator
• Vinay Mehindru, MD, MBA, Founder, Chief Executive Officer, Exemplary Health
• Kent Rogers, Chief Customer Officer, EQRx

6:30 – 7:15 PM

Networking Reception

7:30 – 9:00 PM

Dinner Discussion: Value-Based Care in Action
Value-based cancer care projects are well underway at community oncology practices. This dinner discussion will feature leaders from state practices discussing what they are doing and sharing lessons for others.

• Rajini Katipamula-Malisetti, MD, Minnesota Oncology
• Ed Licitra, MD, PhD, Chairman, Chief Executive Officer, Astera Cancer Care
• Ted Okon, MBA, Executive Director, Community Oncology Alliance, Moderator
• Jay Scott, Director, Managed Care, Minnesota Oncology

7:00 – 8:00 AM

Breakfast

8:00 – 8:10 AM

Day Two Opening Remarks

• Bo Gamble, Director of Quality & Value, Community Oncology Alliance

8:10 – 8:55 AM

New Strategies for Insurance Benefit Designs: From the Simple to the Complex
Insurance benefit designs are ever evolving to provide more benefits to covered lives at a lower cost. Take a dive into new and unique strategies that insurers are employing to drive quality and value from their health care dollars.

• Bret Jackson, President, Economic Alliance for Michigan
• Pete Scruggs, Principal, Golsan Scruggs Insurance & Risk Management, Founder, benefitSmart Cancer Solutions
• Karen van Caulil, PhD, President, Chief Executive Officer, Florida Alliance for Healthcare Value
• Lalan Wilfong, MD, Vice President, Payer Relations & Practice Transformation, The US Oncology Network,
  McKesson, Moderator

9:00 AM – 9:50 AM

Insurer Perspectives on Oncology Reform Efforts & New Payment Models
How are insurers reacting to oncology payment reform? Representatives from national insurers offer their perspective on current reform efforts and what they expect from new and upcoming payment models.

• Michael Diaz, MD, President & Managing Physician, Florida Cancer Specialists & Research Institute, Moderator
• René Frick, Senior Director, Network Innovation & Partnerships, BlueCross BlueShield of South Carolina
• Stacie Mason, Provider Partner Principal, Provider Relations, BlueCross BlueShield of Minnesota
• Ray Parzik, Senior Director, Value Based Contracting, Florida Blue

9:50 – 10:05 AM

Networking Break

10:05 – 11:00 AM

Employer Perspectives on Oncology Reform Efforts & New Payment Models
As the primary payers for health care benefits, employers should have some of the most interest in the success of oncology reform efforts and new payment models. This panel grants attendees an inside look at what employers are thinking about and looking to gain from payment and care delivery reform efforts.

• Bo Gamble, Director of Quality & Value, Community Oncology Alliance, Moderator
• Bill Lacy, MBA, Chief Executive Officer, Association for Corporate Health Risk Management
• Michael Thompson, President, Chief Executive Officer, National Alliance of Healthcare Purchaser Coalitions
• Dickon Waterfield, Chief Commercial Officer, Employer Direct Healthcare

11:05 – 11:55 AM

Cancer Care Team Perspectives on Oncology Reform Efforts & New Payment Models
Over the last decade, cancer care teams have been constantly challenged to adapt to oncology reform efforts and payment models seeking to improve quality, value, and patient outcomes. Hear from practice leaders about their perspectives on efforts to date, as well as the risks and benefits that come from transformation efforts.

• David Cosgrove, MD, Medical Director, Compass Oncology
• Michael Diaz, MD, President & Managing Physician, Florida Cancer Specialists & Research Institute, Moderator
• Scott Kruger, MD, FACP, Medical Director, Virginia Oncology Associates
• Aaron Lyss, MBA, Senior Director, Payment & Policy Innovation, OneOncology

11:55 – 12:30 PM

Lunch & Networking

12:35 – 1:30 PM

Care Delivery & Considerations Outside the Practice: Addressing SDOH & Equity
Cancer care doesn’t begin and end at the doors of the clinic. A multitude of social determinants of health (SDOH) influence a patient’s cancer journey. In this session, we’ll hear from practice professionals who are focusing on addressing SDOH and disparities to improve cancer care for all.

• Stephanie Broussard, MSSW, LCSW-S, APHSW-C, Director of Palliative Care & Social Work, Texas Oncology
• Alti Rahman, MHA/MBA, CSSBB, Practice Administrator, Oncology Consultants
• John Sargent, MD, MSt, Founding Partner, BroadReach Group
• Lalan Wilfong, MD, Vice President, Payer Relations & Practice Transformation, The US Oncology Network, McKesson, Moderator

1:35 – 2:30 PM

Importance of Good Quality Measures in Oncology
When it comes to high quality care, the only way to prove your success is by measures and reporting. This session will walk attendees through the intricacies and importance of oncology quality measures, how they are being used today, and efforts to align measurement across stakeholders.

• Michael Diaz, MD, President & Managing Physician, Florida Cancer Specialists & Research Institute
• Lalan Wilfong, MD, Vice President, Payer Relations & Practice Transformation, The US Oncology Network, McKesson

1:35 – 2:30 PM

Summit Wrap-Up & Predictions